| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
Trial completed |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
date change Completion moved earlier: 2026-10-03 -> 2026-03-31 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Primary completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-28 | NCT05700448 Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal… |
date change Primary completion pushed: 2028-12 -> 2029-12 |
| 2026-05-28 | NCT05700448 Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal… |
date change Completion pushed: 2029-12 -> 2030-12 |
| 2026-05-23 | NCT01190930 Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk… |
Trial completed |
| 2026-05-14 | NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or… |
Trial terminated |
| 2026-05-14 | NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or… |
critical why stopped: null → "\\<75% participation" |
| 2026-05-14 | NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or… |
date change Primary completion moved earlier: 2026-12-31 -> 2026-05-05 |
| 2026-05-14 | NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or… |
date change Completion moved earlier: 2026-12-31 -> 2026-05-05 |
| 2026-05-14 | NCT05602194 Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for… |
overall status: "Recruiting" → "Active Not Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT03914625 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT05700448 | Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal… | Extranodal NK/T-cell Lymphoma | Not Yet Recruiting |
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT05602194 | Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic… | Recurrent B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02112916 | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With… | Adult T Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07072585 | Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With… | Stage II T Lymphoblastic Leukemia/Lymphoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT00501826 | Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute… | T Acute Lymphoblastic Leukemia | Recruiting |
| NCT06124157 | A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT02981628 | Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or… | Recurrent B Acute Lymphoblastic Leukemia | Recruiting |
| NCT01574274 | SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT07574528 | A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in… | NKTCL | Not Yet Recruiting |
| Phase 1 | |||
| NCT03571321 | Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT05157971 | Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |